Table 1.
Summary of respondent characteristics, comparison of estimation and validation datasets
All baseline data | Estimation dataset | Validation dataset | Differencea | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Mean | SD | Observations | Mean | SD | Observations | Mean | SD | Observations | t statistic | p value | |
Measure | |||||||||||
FSS | 43.73 | 15.10 | 1054 | 43.44 | 15.16 | 787 | 44.60 | 14.91 | 267 | −1.085 | 0.278 |
EQ-5D | 0.596 | 0.295 | 1346 | 0.600 | 0.291 | 1005 | 0.584 | 0.309 | 341 | 0.831 | 0.406 |
SF-6D | 0.646 | 0.130 | 632 | 0.650 | 0.135 | 473 | 0.636 | 0.113 | 159 | 1.141 | 0.254 |
MSIS-8D | 0.646 | 0.185 | 690 | 0.647 | 0.190 | 523 | 0.641 | 0.172 | 167 | 0.412 | 0.681 |
Characteristic | |||||||||||
Age | 50.67 | 11.68 | 1400 | 50.74 | 11.73 | 1048 | 50.45 | 11.54 | 352 | 0.402 | 0.688 |
Duration (years) | 9.62 | 10.01 | 1347 | 9.61 | 10.00 | 1009 | 9.68 | 10.09 | 338 | −0.113 | 0.910 |
EDSS score | 4.30 | 2.31 | 289 | 4.32 | 2.34 | 218 | 4.22 | 2.24 | 71 | 0.324 | 0.746 |
Percentage | Observations | Percentage | Observations | Percentage | Observations | chi2 statistic | p value | ||||
Gender | |||||||||||
Female | 73.86% | 1040 | 74.62% | 788 | 71.59% | 252 | 1.256 | 0.262 | |||
Male | 26.14% | 368 | 25.38% | 268 | 28.41% | 100 | |||||
MS type | |||||||||||
Relapsing remitting | 41.97% | 572 | 42.66% | 439 | 39.82% | 133 | 7.572 | 0.109 | |||
Primary progressive | 19.37% | 264 | 18.56% | 191 | 21.86% | 73 | |||||
Secondary progressive | 16.95% | 231 | 17.69% | 182 | 14.67% | 49 | |||||
Benign | 3.3% | 45 | 3.69% | 38 | 2.10% | 7 | |||||
DK or combination | 18.42% | 251 | 17.40% | 179 | 21.56% | 72 | |||||
Missing | 45 | 27 | 18 | ||||||||
Recent relapseb | |||||||||||
Yes | 53.55% | 732 | 53.42% | 546 | 53.91% | 186 | 0.025 | 0.988 | |||
No | 33.28% | 455 | 33.37% | 341 | 33.04% | 114 | |||||
Don’t know | 13.17% | 180 | 13.21% | 135 | 13.04% | 45 | |||||
Missing | 41 | 34 | 7 |
SD standard deviation, FSS Fatigue Severity Scale, EQ-5D EuroQoL EQ-5D-3L, SF-6D Short-Form 6D, MSIS-8D Multiple Sclerosis Impact Scale – Eight Dimensions, EDSS Expanded Disability Status Scale, DK don’t know
aDifference between estimation and validation datasets
bRelapse in the 12 months prior to completing the baseline questionnaire
nb response numbers are lower for the SF-6D and the MSIS-8D as only version 2 of these questionnaires were included